Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
235 hedge funds and large institutions have $3.26B invested in Axonics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 41 increasing their positions, 87 reducing their positions, and 74 closing their positions.
350% more funds holding in top 10
Funds holding in top 10: 4 → 18 (+14)
11% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 74
2% more funds holding
Funds holding: 230 → 235 (+5)
2% more capital invested
Capital invested by funds: $3.19B → $3.26B (+$73M)
20% less call options, than puts
Call options by funds: $17.3M | Put options by funds: $21.6M
53% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 87
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$337M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$121M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$114M |
| 4 |
Axa
Paris,
France
|
-$105M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$80.8M |
AXNX Hedge Fund Activity: Q1 2024 in Review
235 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q1 2024, worth a combined $3.26B — up 2.3% from $3.19B a quarter earlier.
Buyers outnumbered sellers: 82 funds opened new AXNX positions and 74 closed out — a net gain of 8 holders — while 41 added to existing stakes and 87 trimmed.
The largest buyer was UBS O'Connor, adding an estimated $128M. The largest seller was Fidelity Investments, cutting an estimated $337M.
- 235 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q1 2024, up from 230 in Q4 2023.
- Funds reported $3.26B of Axonics, Inc. Common Stock stock for Q1 2024, up 2.3% quarter-over-quarter.
- 82 funds opened new Axonics, Inc. Common Stock positions in Q1 2024 and 74 closed out, a net change of +8 holders.
- The largest Axonics, Inc. Common Stock buyer in Q1 2024 was UBS O'Connor, an estimated $128M added.
- The largest Axonics, Inc. Common Stock seller in Q1 2024 was Fidelity Investments, an estimated $337M sold.
Based on aggregated 13F filings for Q1 2024.